The International Lymphatic Disease and Lymphedema Patient Registry and Biorepository
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Lymphedema
- Sponsor
- Stanford University
- Enrollment
- 5000
- Locations
- 1
- Primary Endpoint
- prevalence of lymphatic disease
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
The purpose of the International Lymphatic Disease and Lymphedema Patient Registry and Biorepository is to collect health information in order to study the disease classification, natural history, and impact of Lymphatic Disease, Lymphedema and Related Disorders and its treatments and medical outcomes.
Detailed Description
This project represents the inauguration of an International Patient Registry for Lymphatic Diseases. This project will be completed through an affiliation with the Lymphatic Education \& Research Network, a non-profit organization whose mission is to promote research and the development of new therapies for patients with lymphatic diseases, including lymphedema. The registry will provide researchers with much-needed clinical data to study the impact of diseases of the lymphatic system, in order to develop improved treatments and find a cure for lymphatic diseases, lymphedema, and related disorders. The establishment of this initiative is a major step forward in research for direct study of groups of patients with lymphatic disease. In the future, this project will be able to be linked with a biorepository, in which tissue and blood samples derived from patients will be made available for research into human disease states. An international patient registry and tissue/cell bank program paves the way for future clinical trials of experimental drugs and therapies designed to treat lymphatic disease in human subjects.
Investigators
Stanley Rockson
Allan and Tina Neill Professor of Lymphatic Research and Medicine
Stanford University
Eligibility Criteria
Inclusion Criteria
- •Presence of lymphatic disease
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
prevalence of lymphatic disease
Time Frame: 15 years
Secondary Outcomes
- socioeconomic impact of lymphatic disease(15 years)